Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04526509 |
| Title | Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | SWE | NLD | DEU | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Jacksonville | Florida | 32224 | United States | Details | |
| GSK Investigational Site | Atlanta | Georgia | 30322 | United States | Details | |
| GSK Investigational Site | Westwood | Kansas | 66205 | United States | Details | |
| GSK Investigational Site | Lexington | Kentucky | 40536 | United States | Details | |
| GSK Investigational Site | Baltimore | Maryland | 21287 | United States | Details | |
| GSK Investigational Site | Saint Louis | Missouri | 63110 | United States | Details | |
| GSK Investigational Site | New York | New York | 10032 | United States | Details | |
| GSK Investigational Site | New York | New York | 10065 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details | |
| GSK Investigational Site | Melbourne | Victoria | 3000 | Australia | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| GSK Investigational Site | Montreal | Quebec | H1T 2M4 | Canada | Details | |
| GSK Investigational Site | Muenchen | Bayern | 81377 | Germany | Details | |
| GSK Investigational Site | Koeln | Nordrhein-Westfalen | 50937 | Germany | Details | |
| GSK Investigational Site | Dresden | Sachsen | 01307 | Germany | Details | |
| GSK Investigational Site | Amsterdam | 1066 CX | Netherlands | Details | ||
| GSK Investigational Site | Stockholm | SE-171 64 | Sweden | Details |